FindTrial
Sign In

Umbilical cord mesenchymal stem cells in the application of hematopoietic stem cell transplantation

Umbilical cord mesenchymal stem cells in the application of hematopoietic stem cell transplantation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCN-15006595
Enrollment
Unknown
Registered
2015-06-15
Start date
2015-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematological malignancies

Interventions

1:mesenchymal stem cells with hematopoietic stem cell transplantation
2:hematopoietic stem cell transplantation

Sponsors

Southwest Hospital, Third Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 18 and 65 years; 2. KPS score > 60 points and estimated survival time > 3 months; 3. With confirmed hematological malignancies and to be treated with hematopoietic stem cell transplantation; 4. Without serious mental illness and serious heart, liver, kidney or pulmonary insufficiency, and other fatal diseases; 5. Agreed to participate in this study, and signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Serious mental patient; 2. Serious heart, liver, kidney or pulmonary insufficiency; 3. In gestation period or suckling period; 4. HIV infection or substance abuse.

Design outcomes

Primary

MeasureTime frame
disease-free survival;overall survival;—

Secondary

MeasureTime frame
Graft implantation rate;Hematopoietic reconstruction rate;incidence of GVHD;—

Countries

China

Contacts

Public ContactChen Jieping
chenjpxn@163.com+86 13983766908

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026